Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash From Cardinal Health In Lieu Of Contingent Milestone Payment

Continuing the Company's Fix, Fund, Propel approach, the cash payment from Cardinal Health aligns strategic goals while solidifying immediate capita

Related Keywords

Dublin ,Ireland ,Ohio ,United States ,Colorado ,American ,Theodore Gerbick ,Navidea Manocept ,Jason Myers ,Company Phase Iib ,Cardinal Health ,Cardinal Health Inc ,Navidea Biopharmaceuticals Inc ,Securities Exchange ,News Global ,Navidea Biopharmaceuticals ,Asset Purchase Agreement ,Milestone Payment ,Keystone Capital Partners ,Executive Consultants ,Keystone Partners ,Securities Act ,Securities Exchange Act ,Annual Report ,